Bank Of New York Mellon Corp Organogenesis Holdings Inc. Transaction History

Bank Of New York Mellon Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.48 - $3.43 $2.07 Million - $2.86 Million	834,854 New	834,854 $2.25 Million
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $190,048 - $389,175	60,525 Added 9.73%	682,601 $2.21 Million
Q2 2022 Aug 15, 2022	SELL	$4.74 - $8.15 $70,758 - $121,663	-14,928 Reduced 2.34%	622,076 $3.04 Million
Q1 2022 May 11, 2022	BUY	$6.47 - $9.57 $455,792 - $674,177	70,447 Added 12.43%	637,004 $4.85 Million
Q4 2021 Feb 11, 2022	BUY	$9.02 - $13.5 $525,162 - $785,997	58,222 Added 11.45%	566,557 $5.23 Million
Q3 2021 Nov 12, 2021	BUY	$13.71 - $17.18 $1.27 Million - $1.59 Million	92,690 Added 22.3%	508,335 $7.24 Million
Q2 2021 Aug 11, 2021	BUY	$14.92 - $23.23 $3.93 Million - $6.12 Million	263,566 Added 173.31%	415,645 $6.91 Million
Q1 2021 May 13, 2021	BUY	$7.33 - $21.06 $403,509 - $1.16 Million	55,049 Added 56.73%	152,079 $2.77 Million
Q4 2020 Feb 09, 2021	BUY	$3.63 - $7.53 $149,283 - $309,671	41,125 Added 73.56%	97,030 $730,000
Q3 2020 Nov 12, 2020	BUY	$3.29 - $4.58 $1,865 - $2,596	567 Added 1.02%	55,905 $214,000
Q2 2020 Aug 12, 2020	BUY	$2.86 - $4.61 $77,114 - $124,299	26,963 Added 95.02%	55,338 $212,000
Q1 2020 May 06, 2020	BUY	$2.92 - $5.31 $6,234 - $11,336	2,135 Added 8.14%	28,375 $91,000
Q3 2019 Nov 07, 2019	SELL	$3.57 - $8.09 $4,658 - $10,557	-1,305 Reduced 4.74%	26,240 $172,000
Q2 2019 Aug 12, 2019	BUY	$6.58 - $8.69 $181,246 - $239,366	27,545 New	27,545 $210,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.